Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A)

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 7, pp. 1229-1239

  2. New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study

    European Neuropsychopharmacology, Vol. 60, pp. 38-47

2020

  1. Analysis of KCNH2 and CACNA1C schizophrenia risk genes on EEG functional network modulation during an auditory odd-ball task

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 270, Núm. 4, pp. 433-442

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2014

  1. Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia

    Annals of General Psychiatry, Vol. 13, Núm. 1

2011

  1. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients

    NeuroImage, Vol. 56, Núm. 1, pp. 45-51

2008

  1. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)

    Genes, Brain and Behavior, Vol. 7, Núm. 7, pp. 796-801

2007

  1. Effect of interleukin-1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, Núm. 8, pp. 1090-1093

2005

  1. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene

    NeuroImage, Vol. 27, Núm. 4, pp. 1002-1006